Locations:

Tag: prostate cancer

June 17, 2019/Cancer

Study Verifies IsoPSA’s Utility as a Prostate Cancer Biomarker

Test can identify aggressive vs. indolent disease, reduce unneeded biopsies

March 14, 2019/Cancer

Active Surveillance a Reasonable Option in African-American Men with Low-Risk Prostate Cancer

Study sheds new light on the utility of watchful waiting

March 5, 2019/Cancer

Study Demonstrates Association Between Urologic Oncology Fellowship Training and Diagnostic Yield on Prostate Biopsy

Advanced training is linked to positive biopsy findings

January 22, 2019/Cancer

Study Validates Clinical Criteria for Very High-Risk Localized Prostate Cancer

Data analyzed from three centers

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

October 22, 2018/Cancer/Research

Ten-Year Outcomes of Moderately Hypofractionated IMRT in Prostate Cancer

Higher doses don’t mean higher toxicity

October 12, 2018/Cancer/Genomics

Using Next-Generation Sequencing to Target Tumor Genomics in Metastatic Prostate Cancer

Actionability of tumor DNA data remains limited

October 2, 2018/Basic & Translational Science

Functional PET Imaging to Identify Prostate Cancer Treatment Resistance

Research has clear implications for future of prostate cancer imaging

September 24, 2018/Urology & Nephrology/Urology

Preparedness for Prostatectomy

Men prepared through group education report better urinary function outcomes

August 3, 2018/Basic & Translational Science

New Center Aims to Produce Practice-Changing Discoveries in Genitourinary Cancer

Fostering collaboration between basic, translational scientists and clinicians

June 25, 2018/Cancer

Localized Therapy for High-Risk Prostate Cancer Improves Outcomes

13-year retrospective shows evolution of treatment for aggressive disease

BackPage 3 of 4Next